John McGrath Net Worth & Insider Trades

John McGrath - EVP & Chief Financial Officer, Atara Biotherapeutics, Inc

As of March 20, 2018

What is John McGrath's Net Worth?

The current estimated net worth of Atara Biotherapeutics, Inc's EVP & Chief Financial Officer, John McGrath, is estimated to be about $5.59M . John McGrath owns about 88,762 units of Atara Biotherapeutics, Inc common stock. In the last 4 years at Atara Biotherapeutics, Inc, John McGrath has sold an estimated value of $6.85M worth.

What is John McGrath's Past Insider Trading?

John McGrath's largest purchase order was 30,000 units , worth over $330K on January 12, 2018. John McGrath's largest sale order was 37,000 units , worth over $900.82K on January 12, 2018. In total, John McGrath has made about 31 transactions over 4 years of their time at Atara Biotherapeutics, Inc. John McGrath usually trades in February, with the busiest year in 2017 and 2015. The most recent transaction was a sale order of 6,000 units , worth over $242.46K on March 20, 2018.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is John McGrath's' Mailing Address?

  • Mailing address is 6900 Paseo Padre Parkway Fremont CA 94555 CA

Atara Biotherapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Pascal Touchon, D.V.M. 2020 $654,857 $422,500 $2,235,600 $1,959,208 $13,662 $5,285,827
Pascal Touchon, D.V.M. 2019 $319,327 $334,791 $2,861,712 $3,049,718 $71,760 $6,637,307
Jakob Dupont, M.D. 2020 $319,231 $143,346 $443,075 $1,757,296 $133,297 $2,796,245
Utpal Koppikar 2020 $460,947 $187,032 $885,431 $597,073 $7,470 $2,137,953
Utpal Koppikar 2019 $439,875 $155,606 $1,034,714 $909,080 $895 $2,540,170
Utpal Koppikar 2018 $240,289 $189,771 $1,903,500 $1,886,325 $398 $4,220,282
Joseph Newell 2020 $466,055 $203,435 $1,033,965 $566,713 $895 $2,251,063
Joseph Newell 2019 $390,000 $155,208 $1,240,675 $932,390 $895 $2,719,167
Joseph Newell 2018 $365,000 $155,490 $895,000 $1,060,710 $16,092 $2,492,292
Kristin Yarema, Ph.D. 2020 $368,308 $147,995 $668,250 $1,067,484 $184,370 $2,436,407
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1604464/000156459021020128/atra-def14a_20210608.htm

What are Atara Biotherapeutics, Inc's Past Insider Trades?

Atara Biotherapeutics, Inc's most recent insider trade came on August 18, 2022 by Pascal Touchon who sold 14,806 units worth $74.55K . In the last 8 years, insiders at Atara Biotherapeutics, Inc have sold an estimated value of $73.12M and bought an estimated value of $10.47M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Isaac E Ciechanover, Chief Executive Officer,  Christopher Haqq, EVP,  and Joe Newell, Chief Operations Officer .

Atara Biotherapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1